Cipla
Michele Crawley, MS, RAC, is a seasoned regulatory affairs professional with extensive experience in the pharmaceutical and animal health industries. Currently serving as Director of Regulatory Affairs at Cipla since February 2015, Michele has previously held the positions of Senior Manager in Regulatory Affairs and Regulatory Affairs Manager at Piedmont Pharmaceuticals, focusing on companion animal health and the submission of novel dosage forms. Michele's career commenced at Banner Pharmacaps, where various roles of increasing responsibility were held, contributing to the establishment of the regulatory affairs function. Michele holds a Master of Science in Chemical and Life Science from the University of Maryland and a Bachelor of Science in Business Administration, Management, and Operations from High Point University.
This person is not in the org chart
This person is not in any offices
Cipla
18 followers
Cipla is a pharmaceutical company. The Company's strategic business units include Active Pharmaceutical Ingredients (APIs), Respiratory and Cipla Global Access. The Company's geographical segments include India, USA, South Africa and Rest of the World. The Company manufactures metered dose inhalers, dry powder inhalers, nasal sprays, nebulizers and a range of inhaled accessory devices. Cipla Global Access is a tender-based institutional business that concentrates on approximately four therapy areas: human immunodeficiency virus/acquired immuno deficiency syndrome (HIV/AIDS), malaria, multi drug-resistant tuberculosis and reproductive health. The Company offers its products for the therapeutic areas, including cardiovascular, children's health, dermatology and cosmetology, diabetes, HIV/AIDS, infectious diseases and critical care, malaria, neurosciences, oncology, ophthalmology, osteoporosis, respiratory, urology and women's health.